PerkinElmer, Shanghai Haoyuan Biotech Co. Ltd. deal

Perkin acquired infectious disease diagnostics company Shanghai Haoyuan for $38 million in cash and revenue-based milestones. Shanghai Haoyuan markets nucleic acid-based blood screening and molecular ...